Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

FDA Approval of Donanemab‐azbt: A New Dawn in Alzheimer's Disease Treatment

Saved in:
Bibliographic Details
Published in:Health Science Reports
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1868847780240293888
collection WordPress RSS
FRELIP Feed Integration
container_title Health Science Reports
description
discipline_display Health and Safety
discipline_facet Health and Safety
format Online Article
RSS Article
genre Journal Article
id rss_article:95053
institution FRELIP
journal_source_facet Health Science Reports
last_indexed 2026-06-24T03:35:28.979Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle FDA Approval of Donanemab‐azbt: A New Dawn in Alzheimer's Disease Treatment
Health and Safety
General
Health and Safety
sub_discipline_display General
sub_discipline_facet General
subject_display Health and Safety
General
Health and Safety
subject_facet Health and Safety
General
Health and Safety
title FDA Approval of Donanemab‐azbt: A New Dawn in Alzheimer's Disease Treatment
title_alt Aprobación de donanemab-azbt por la FDA: un nuevo amanecer en el tratamiento de la enfermedad de Alzheimer
Approbation par la FDA du donanemab-azbt : une nouvelle aube dans le traitement de la maladie d'Alzheimer
Aprovação pela FDA de Donanemabe-azbt: Um Novo Amanhecer no Tratamento da Doença de Alzheimer
title_auth FDA Approval of Donanemab‐azbt: A New Dawn in Alzheimer's Disease Treatment
title_es_txt Aprobación de donanemab-azbt por la FDA: un nuevo amanecer en el tratamiento de la enfermedad de Alzheimer
title_fr_txt Approbation par la FDA du donanemab-azbt : une nouvelle aube dans le traitement de la maladie d'Alzheimer
title_full FDA Approval of Donanemab‐azbt: A New Dawn in Alzheimer's Disease Treatment
title_fullStr FDA Approval of Donanemab‐azbt: A New Dawn in Alzheimer's Disease Treatment
title_full_unstemmed FDA Approval of Donanemab‐azbt: A New Dawn in Alzheimer's Disease Treatment
title_pt_txt Aprovação pela FDA de Donanemabe-azbt: Um Novo Amanhecer no Tratamento da Doença de Alzheimer
title_short FDA Approval of Donanemab‐azbt: A New Dawn in Alzheimer's Disease Treatment
title_sort fda approval of donanemab‐azbt: a new dawn in alzheimer's disease treatment
topic Health and Safety
General
Health and Safety
url https://onlinelibrary.wiley.com/doi/10.1002/hsr2.72688?af=R